全球青光眼手术器材市场 - 市场规模（按细分市场）、份额、监管、报销、治疗、预测（~2033）

世界各地青光眼发病率和盛行率的增加以及人口老化是导致不可逆性失明的主要原因，而预防不可逆性失明的最佳预防措施是排出眼内液体。必须这样做。 因此，带阀门和不带阀门的排水设备的销售量预计将增加。

青光眼手术设备在欧美市场有着悠久的历史，在亚太、南美洲等新兴市场也颇有建树。

本报告研究和分析了全球青光眼手术设备市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

已上市的青光眼手术设备和不断变化的竞争格局

• 对主要产业趋势的考虑
• 青光眼手术设备市场年收入与市场前景（按细分市场）（2015-2033）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 青光眼手术器械市场SWOT分析
• 青光眼手术设备市场竞争动态的思考与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Glaukos Corp
• AbbVie Inc
• Alcon Inc
• Johnson & Johnson
• New World Medical
• Incorporated
• Aurolab
• Santen Pharmaceutical Co Ltd
• Nova Eye Medical Ltd
• 其他

Abstract

Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond. Aging population coupled with increase in incidence and prevalence of glaucoma globally is the leading cause of irreversible vision loss, and best preventive measure to stop the irreversible vision loss is drainage of fluids from the eyes. This is expected to increase sales of valved and non-valved drainage devices.

Glaucoma Surgery Devices have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Glaucoma Surgery Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Glaucoma Surgery Devices market.
• Competitive dynamics insights and trends provided for Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Glaucoma Surgery Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Glaucoma Surgery Devices.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Glaucoma Surgery Devices.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Glaucoma Surgery Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Glaucoma Surgery Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable